Peer Review History

Original SubmissionOctober 30, 2020
Decision Letter - Guy Smagghe, Editor

PONE-D-20-34201

One Health, One Hive: A scoping review of honey bees, climate change, pollutants, and antimicrobial resistance

PLOS ONE

Dear Dr. Otto,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Jul 30 2021 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.
  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.
  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Guy Smagghe, PhD

Academic Editor

PLOS ONE

Journal Requirements:

Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. We note that Figure 3 in your submission contain map images which may be copyrighted. All PLOS content is published under the Creative Commons Attribution License (CC BY 4.0), which means that the manuscript, images, and Supporting Information files will be freely available online, and any third party is permitted to access, download, copy, distribute, and use these materials in any way, even commercially, with proper attribution. For these reasons, we cannot publish previously copyrighted maps or satellite images created using proprietary data, such as Google software (Google Maps, Street View, and Earth). For more information, see our copyright guidelines: http://journals.plos.org/plosone/s/licenses-and-copyright.

We require you to either (1) present written permission from the copyright holder to publish these figures specifically under the CC BY 4.0 license, or (2) remove the figures from your submission:

2.1.    You may seek permission from the original copyright holder of Figure 3 to publish the content specifically under the CC BY 4.0 license. 

We recommend that you contact the original copyright holder with the Content Permission Form (http://journals.plos.org/plosone/s/file?id=7c09/content-permission-form.pdf) and the following text:

“I request permission for the open-access journal PLOS ONE to publish XXX under the Creative Commons Attribution License (CCAL) CC BY 4.0 (http://creativecommons.org/licenses/by/4.0/). Please be aware that this license allows unrestricted use and distribution, even commercially, by third parties. Please reply and provide explicit written permission to publish XXX under a CC BY license and complete the attached form.”

Please upload the completed Content Permission Form or other proof of granted permissions as an "Other" file with your submission.

In the figure caption of the copyrighted figure, please include the following text: “Reprinted from [ref] under a CC BY license, with permission from [name of publisher], original copyright [original copyright year].”

2.2.    If you are unable to obtain permission from the original copyright holder to publish these figures under the CC BY 4.0 license or if the copyright holder’s requirements are incompatible with the CC BY 4.0 license, please either i) remove the figure or ii) supply a replacement figure that complies with the CC BY 4.0 license. Please check copyright information on all replacement figures and update the figure caption with source information. If applicable, please specify in the figure caption text when a figure is similar but not identical to the original image and is therefore for illustrative purposes only.

The following resources for replacing copyrighted map figures may be helpful:

USGS National Map Viewer (public domain): http://viewer.nationalmap.gov/viewer/

The Gateway to Astronaut Photography of Earth (public domain): http://eol.jsc.nasa.gov/sseop/clickmap/

Maps at the CIA (public domain): https://www.cia.gov/library/publications/the-world-factbook/index.html and https://www.cia.gov/library/publications/cia-maps-publications/index.html

NASA Earth Observatory (public domain): http://earthobservatory.nasa.gov/

Landsat: http://landsat.visibleearth.nasa.gov/

USGS EROS (Earth Resources Observatory and Science (EROS) Center) (public domain): http://eros.usgs.gov/#

Natural Earth (public domain): http://www.naturalearthdata.com/

3. Please upload a copy of Supporting Information File S6 which you refer to in your text on page 37.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: N/A

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: This manuscript is about a scoping review to investigate interactions between climate change and AMR.

The authors describe that 37 articles were excluded because they were unable to locate full-text pdfs. I wonder which efforts were done to get access to these papers. The authors could be invited to send reprints or by interlibrarian service you could have asked for a copy of the paper. Are the authors sure that you didn't miss valuable information doing so?

I have checked a few references and I believe that the numbering is not correct. For instance page 20, lines 270-271, the paper on horizontal gene transfer is definitely 58 and not 59. The same on page 21, lines 282-285: this should be 61 and 62, and not 63. Please check the entire document carefully.

I would like to see some more criticism in the discussion section. For instance horizontal gene transfer: how frequently has it been described in the context of bee pathogens?

Page 21, lines 276-278: do you suggest here that cell membrane transporters are used to eliminate antimicrobials from the cytoplasm? Please explain better.

Another criticism that is lacking. In the paper of Gregorc et al (19) the authors examined gene expression of pesticide exposed in vitro reared larvae. Differences were found in some immunity-related genes like AMPs. However, challenge infection was done with varroa mites and not with bacteria or viruses. Does this allow to make any conclusions about immuno-competence? May be yes, but it is important to dig deeper in the refered papers.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

Revision 1

Reviewer’s Comments to the Author

Reviewer #1: This manuscript is about a scoping review to investigate interactions between climate change and AMR.

Comment 1: The authors describe that 37 articles were excluded because they were unable to locate full-text pdfs. I wonder which efforts were done to get access to these papers. The authors could be invited to send reprints or by interlibrarian service you could have asked for a copy of the paper. Are the authors sure that you didn't miss valuable information doing so?

Response: Lines 153-158 (version with tracked changes)

Please see the added text to address the concern about missing articles. Second, in our review of this list, we were able to identify one additional article that was now available to us through our library. We have now included 22 articles in the study and revised the text, numbers, and citations throughout the document to reflect this. We recognize the importance of the remaining 36 excluded articles and ensured that every effort was made to locate them. We first utilized both University of Alberta and University of Guelph libraries, and when those resources were exhausted we turned to the interlibrary loan programs at both institutions to recover the remaining articles. Through the interlibrary loan we were able to locate a further 6 articles which we included within the screening process. The remaining 36 articles could not be found. We have described this extra step within our manuscript.

Comment 2: I have checked a few references and I believe that the numbering is not correct. For instance page 20, lines 270-271, the paper on horizontal gene transfer is definitely 58 and not 59. The same on page 21, lines 282-285: this should be 61 and 62, and not 63. Please check the entire document carefully.

Response Lines 478-639 (version with tracked changes): Thank you for finding this error. We have fixed and included the corrected bibliography, including the added reference mentioned above.

Comment 3: I would like to see some more criticism in the discussion section. For instance horizontal gene transfer: how frequently has it been described in the context of bee pathogens?

Responses:

Lines 368-377 (version with tracked changes): We appreciate the reviewer’s concern about being critical of the included literature. We did not conduct a risk of bias assessment as it is not a requirement for systematic scoping reviews according to JBI and PRISMA-ScR. However, we have included some statements in this section about the quality of the included literature and have highlighted some specific concerns.

Lines 290-293 (version with tracked changes): Regarding HGT, this was not a specific theme that emerged from the scoping review. We brought in the idea about HGT to link to the broader discussion on honey bee immunity and the idea insects could actually transfer genes back and forth between bacteria. As papers that linked AMR and CC/EP did not include HGT directly, we did not assess this frequency. We merely posit this as an area for future interest and research as it was not a direct finding of the review. As a result, we do not spend time formally evaluating the merits of the specific papers and conclude the paragraph by stating that evidence of transfer of AMR genes through these mechanisms remains largely unstudied. Further evaluation of these mechanisms are outside of the scope of this paper, which is focused on the link between AMR and Climate Change or AMR and environmental pollution in honey bee health. We brought in this idea from papers that supported the idea linked to changes in the microbiota of the honeybees and the fact that they are continuously exposed to pesticides and then transfer these things to pathogens in the honeybee gut.

Comment 4: Page 21, lines 276-278: do you suggest here that cell membrane transporters are used to eliminate antimicrobials from the cytoplasm? Please explain better.

Response Lines 290-298 (version with tracked changes): Thank you for highlighting this need for clarification. We have modified the text to better explain the causal pathway from transporter upregulation to AMR risk.

Comment 5: Another criticism that is lacking. In the paper of Gregorc et al (19) the authors examined gene expression of pesticide exposed in vitro reared larvae. Differences were found in some immunity-related genes like AMPs. However, challenge infection was done with varroa mites and not with bacteria or viruses. Does this allow to make any conclusions about immuno-competence? May be yes, but it is important to dig deeper in the refered papers.

Response Lines 245-252 (version with tracked changes): Thank you for this important comment. We recognize the need to clarify how we decided to “bin” articles. Although a full discussion of honey bee immune pathways is beyond the scope of this paper, we have made edits to better acknowledge how pest and parasite exposure is linked to immunocompetence.

To provide further clarification, we explain the specific case of Gregorc et al. (2012) here for the reviewer’s benefit.

Morbidity as a result of Varroa mite exposure occurs via cellular invasion of Deformed Wing Virus, Escherichia coli, or other secondary infection. This clarification has been included.

Gregorc et al. (2012) explored immunocompetence via titres of deformed wing virus as well as other secondary pathogens in response to varroa mite exposure. “Loads for DWV and IAPV were elevated in bees challenged with Varroa (Fig. 1A), an expected result given that Varroa is a potential vector of these and other honey bee RNA viruses (Chen and Siede, 2007). This result was confirmed for Deformed Wing Virus in individual larvae, whereby larvae exposed to mites had a 900-fold higher average load for DWV (n = 113 and 94 assayed bees; Fig. 2).“

Table 2 line 19 in our manuscript highlights this viral focus of the paper and therefore its “immunocompetence tag”. The challenge by Varroa mite in this case was listed only under health aspects of concern, while the immunocompetence conclusions were drawn from the microbe of interest--deformed wing virus.

Further, honey bee immune responses overlap significantly for various types of pathogens. This generalization is implied Gregorc et al. in their reference to “xenobiotic detoxification.” For example, antimicrobial peptides such as defensin have wide broad spectrum efficacy and are upregulated in response to Fungi, Bacteria, Viruses, and parasites (see DOI: 10.2478/v10289-012-0013-y).

Attachments
Attachment
Submitted filename: Response to Reviewers.pdf
Decision Letter - Guy Smagghe, Editor

One Health, One Hive: A scoping review of honey bees, climate change, pollutants, and antimicrobial resistance

PONE-D-20-34201R1

Dear Dr. Otto,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Guy Smagghe, PhD

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Formally Accepted
Acceptance Letter - Guy Smagghe, Editor

PONE-D-20-34201R1

One Health, One Hive: A scoping review of honey bees, climate change, pollutants, and antimicrobial resistance

Dear Dr. Otto:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Prof. Guy Smagghe

Academic Editor

PLOS ONE

Open letter on the publication of peer review reports

PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.

We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.

Learn more at ASAPbio .